You are viewing the site in preview mode

Skip to main content

Advertisement

Table 5 Average and Incremental Cost and Effect Outcomes per Pregnant Woman per Annum

From: Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants

  Strategy Cost ($) Effect (LYG) Incremental Cost ($) Incremental Effect (LYG) ICER
J Universal screening by 14 weeks gestation and screening of the infant at birth -737.70 0.2037    
H Universal screening by 14 weeks gestation or screening at the onset of labour or screening of the infant at birth -730.55 0.2013 7.15 -0.0023 Dominated
F Universal screening by 14 weeks gestation or screening of the infant at birth -718.82 0.2001 18.88 -0.0036 Dominated
I Universal screening by 14 weeks gestation and screening at the onset of labour -646.90 0.1627 90.81 -0.0409 Dominated
E Universal screening by 14 weeks gestation or screening at the onset of labour -639.95 0.1636 97.76 -0.0400 Dominated
B Universal screening by 14 weeks gestation -600.54 0.1485 137.16 -0.0552 Dominated
G Universal screening at the onset of labour or screening the infant at birth -298.17 0.1443 439.54 -0.0594 Dominated
C Universal screening at the onset of labour -89.46 0.0389 648.24 -0.1648 Dominated
D Universal screening of the infant at birth -75.02 0.1409 662.69 -0.0628 Dominated
A Sporadic screening 714.05 0.0000 1451.75 -0.2037 Dominated